This course has concluded on February 10, 2021

CE InformationCourse Outline

    Prescription Digital Therapeutics: How reSET® and reSET-O® are Bridging Gaps in the Treatment of SUD and OUD

    If you receive an error message

    Make sure you first create a NACCME account before you access the evaluation. Please click register at the top right of your screen. 

    FACULTY

    Adam Rubinstein, MD, FASAM
    Private Practice Physician
    Vernon Hills, Illinois

    PROVIDER STATEMENT

     

    Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

    For questions regarding this educational activity, please call 609-630-6277 or email mpangaro@naccme.com

    INTENDED LEARNERS

    This activity is designed for clinicians in the addiction treatment field.

    LEARNING OBJECTIVES

    This webinar will:

    • Provide an overview of PDTs and share how they are being integrated into the standard of care.
    • Explain how reSET and reSET-O are being used today to improve access for patients and bridge gaps in the treatment of SUD and OUD.
    • Present insights and engagement metrics from the commercial use of reSET and reSET-O and show how they are helping clinicians deliver better care.

    CLAIMING CREDIT

    To be eligible for credit, participants must complete the evaluation immediately following the live activity. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

    ADDICTION COUNSELORS

    This course has been approved by NACCME, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840.  NACCME is responsible for all aspects of the programming.

    USE OF PROPRIETARY NAMES

    This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

    DISCLAIMERS

    The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

    Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

    The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

    DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

    NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

    NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

    According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

    Planning Committee

    In addition to the faculty listed below, NACCME planners and staff include Greaton Sellers, Samantha Conforti, Melissa Pangaro, Randy Robbin, and Margie Stefan.

    All planning committee members have disclosed no relevant financial relationships with any commercial interests.

    Faculty
    The faculty has reported the following:

    Dr. Rubinstein: Consultant— Pear Therapeutics

    ADA STATEMENT

    North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

    PRIVACY POLICY

    NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

    Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.